INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2018

In clinical trials, intermittent fasting and caloric restriction produce similar weight loss and improvements in insulin sensitivity.

This review examined underlying mechanisms and benefits of intermittent fasting (IF) across animal models and clinical trials. Most human IF studies reported minimal weight loss and marginal improvements in metabolic biomarkers, though results varied, while clinical trials showed IF and caloric restriction led to similar weight loss and insulin sensitivity improvements. Animal models indicated benefits including reduced oxidative stress, improved cognition, delayed aging, anti-inflammatory effects, enhanced autophagy, and gut microbiome benefits. The authors noted that existing IF trials have featured moderate sample sizes and limited duration, underscoring the need for more rigorous research.

Study type
Narrative review
Who was studied
Human clinical trials and animal models
What was measured
Weight loss, metabolic biomarkers, and insulin sensitivity

THE PAPER

Intermittent Fasting: Is the Wait Worth the Weight?

Stockman MC, Thomas D, Burke J, Apovian CM. Curr Obes Rep, 2018.

PubMed 29700718 ↗DOI 10.1152/japplphysiol.00846.2016 ↗

Diabetes & blood sugarNutrients & adequacyWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.